UY38939A - Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva - Google Patents

Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva

Info

Publication number
UY38939A
UY38939A UY0001038939A UY38939A UY38939A UY 38939 A UY38939 A UY 38939A UY 0001038939 A UY0001038939 A UY 0001038939A UY 38939 A UY38939 A UY 38939A UY 38939 A UY38939 A UY 38939A
Authority
UY
Uruguay
Prior art keywords
methods
compositions
sports medicine
medicine applications
cannabinoid compositions
Prior art date
Application number
UY0001038939A
Other languages
English (en)
Inventor
Peyton Palaio
Original Assignee
Prec Biologics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prec Biologics filed Critical Prec Biologics
Publication of UY38939A publication Critical patent/UY38939A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan composiciones que comprenden un cannabinoide, un aceite (por ejemplo, aceite MCT o aceite de coco) y una cera, y métodos para preparar tales composiciones. Las composiciones divulgadas pueden ser útiles, por ejemplo, en el tratamiento de una lesión del músculo, articulación, cartílago y/o tendón. Este resumen está destinado a ser una herramienta de exploración con el propósito de buscar en la técnica particular y no pretende ser una limitación de la presente invención.
UY0001038939A 2019-10-30 2020-10-30 Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva UY38939A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962928206P 2019-10-30 2019-10-30

Publications (1)

Publication Number Publication Date
UY38939A true UY38939A (es) 2022-04-29

Family

ID=75686693

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001038939A UY38939A (es) 2019-10-30 2020-10-30 Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva

Country Status (4)

Country Link
US (1) US20210128521A1 (es)
AR (1) AR120350A1 (es)
UY (1) UY38939A (es)
WO (1) WO2021086964A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11058142B1 (en) 2020-10-01 2021-07-13 Tobacco Technology, Inc. Shisha, heat-not-burn, or combustion casing with active ingredient, product and casing with active ingredient, and method of making the same
WO2022072031A1 (en) 2020-10-01 2022-04-07 Tobacco Technology, Inc. Shisha, heat-not-burn, or combustion casing, product, and method of making the same
WO2023076928A1 (en) 2021-10-26 2023-05-04 Ecofibre Limited Methods of treating ovarian cancer with hemp extract
CA3235077A1 (en) 2021-10-26 2023-05-04 Alex Nance Systems and methods for producing hemp extracts and compositions
AU2022379618A1 (en) 2021-10-26 2024-05-23 Ecofibre USA Inc. Methods of treating endometriosis and other non-cancer gynecological disorders with hemp extract

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
WO2015142501A1 (en) * 2014-03-21 2015-09-24 Bodybio Inc. Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids
US20160338974A1 (en) * 2015-03-02 2016-11-24 Afgin Pharma, Llc Topical regional neuro affective therapy with cannabinoid combination products
JP2021518332A (ja) * 2018-03-14 2021-08-02 ポビバ コーポレーションＰｏｖｉｖａ Ｃｏｒｐ． 親油性の活性薬剤の経皮及び／又は皮膚送達
WO2019186544A1 (en) * 2018-03-26 2019-10-03 Raphael Luxenbourg Topical cannabidiol compositions and methods for protecting the skin from ultra-violet radiation

Also Published As

Publication number Publication date
AR120350A1 (es) 2022-02-09
US20210128521A1 (en) 2021-05-06
WO2021086964A1 (en) 2021-05-06

Similar Documents

Publication Publication Date Title
UY38939A (es) Métodos de uso de composiciones de cannabinoides en aplicaciones de medicina deportiva
ECSP19010079A (es) 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2
CO2019002371A2 (es) Adenovirus armado con captador biespecífico de linfocitos t (bite)
CO2020015156A2 (es) Compuestos inhibidores de rip1 y métodos para preparar y usar los mismos referencia cruzada a una solicitud relacionada
CL2018000320A1 (es) Coadyuvantes basados en aceite (divisional de solicitud 201600650)
BR112018075986A2 (pt) método indireto de reparação de tecido articular
CL2017000902A1 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
AR102372A1 (es) Composición que comprende una mezcla de extractos vegetales o una mezcla de moléculas contenidas en dichos vegetales, y su utilización para actuar sobre el metabolismo glucídico y/o lipídico
UY38237A (es) Derivados sustituidos de la carboxamida dihidropirazolo pirazina
CR20190105A (es) Composiciones y métodos de inhibir masp-3 para el tratamiento de diversas enfermedades y trastornos
CR20170425A (es) Nuevas proteínas específicas para pioverdina y pioquelina
BR112017012184A2 (pt) composições e métodos para reticular polímeros na presença de oxigênio atmosférico
CO2019011546A2 (es) Compuestos y métodos para el tratamiento de enfermedades parasitarias
BR112018073711A2 (pt) dispositivo de distração osteogênica telescópico intracorporal, dispositivo de produção de força extracorporal, método de alongamento de osso e disposição de alongamento de osso
CY1123623T1 (el) Θεραπεια νευρολογικων νοσων
CO2022010547A2 (es) Compuestos y usos de los mismos
AR105778A1 (es) Composiciones de materia grasa y métodos para fabricarlas y sus usos
CY1124677T1 (el) (1s,4s)-4-(2-(((3s,4r)-3-φθoροtetpaϋδpo-2h-πypan-4-yλ)amino)-8-((2,4,6-τριχλωροφαινυλ)αμινο)-9η-πουριν-9-υλ)-1-μεθυλοκυκλοεξανο-1-καρβοξαμιδιο και μεθοδοι χρησης αυτου
CL2020000334A1 (es) Formas cristalinas de 2-[(2,4-diclorofenil)metil]-4,4-dimetil-isoxazolidin-3-ona.
DOP2023000219A (es) Compuestos de tienopirrol
CL2021001044A1 (es) Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrización de heridas y la recuperación posoperatoria
AR109397A1 (es) Polietilenos modificados
CO2021000884A2 (es) Composiciones de esterquat
AR112466A1 (es) Complejo cosmético para la hidratación bioactiva, composición cosmética, uso y método
CR20190391A (es) Derivados de pirazol como inhibidores de bromodominio